Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study
Most individuals living with IPF experienced significant challenges due to their disease and its treatment, that substantially impacted their quality of life. A better understanding of these challenges can facilitate patient-centered and shared decision-making, ultimately enhancing outcomes and satisfaction for people living with IPF.
Authors
- Lisa Lancaster (ORCID: https://orcid.org/0000-0001-8465-7357)
- Tejaswini Kulkarni (ORCID: https://orcid.org/0000-0002-4251-4988)
- Frank B. Salisbury
- Jessica Shore
- Camilla S. Graham (ORCID: https://orcid.org/0000-0003-0515-364X)
- Brad Bisson
- Emily Pardy
Institutions
- Ifm Therapeutics (United States) (US)
- Pulmonary Fibrosis Foundation (US)
- PureTech (United States) (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1186/s12890-025-03689-8
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52